Edition:
United Kingdom

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

56.90USD
15 Dec 2017
Change (% chg)

$1.85 (+3.36%)
Prev Close
$55.05
Open
$55.13
Day's High
$57.42
Day's Low
$55.13
Volume
2,010,509
Avg. Vol
624,399
52-wk High
$57.79
52-wk Low
$11.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.33 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 3 3
(2) OUTPERFORM 4 5 5 4
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.70 1.78 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 8 40.31 48.10 37.52 52.55
Quarter Ending Mar-18 5 38.67 48.60 28.50 56.81
Year Ending Dec-17 8 252.51 260.30 249.76 206.47
Year Ending Dec-18 8 222.30 394.90 126.20 259.04
Earnings (per share)
Quarter Ending Dec-17 8 -0.33 -0.26 -0.40 -0.21
Quarter Ending Mar-18 6 -0.33 -0.25 -0.40 -0.12
Year Ending Dec-17 8 -0.74 -0.67 -0.81 -0.83
Year Ending Dec-18 8 -0.93 0.22 -1.58 -0.58

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 117.32 152.93 35.61 30.35
Quarter Ending Jun-17 34.23 34.59 0.36 1.05
Quarter Ending Mar-17 26.80 24.73 2.07 7.73
Quarter Ending Dec-16 40.67 37.45 3.22 7.92
Quarter Ending Sep-16 32.89 36.34 3.44 10.47

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 40.31 40.31 39.05 35.75 52.55
Quarter Ending Mar-18 38.67 38.67 37.06 32.10 56.81
Year Ending Dec-17 252.51 252.51 248.67 209.60 206.47
Year Ending Dec-18 222.30 222.30 213.05 189.61 259.04

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 0
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings